We are live on ! Find out more
SYNB

Putnam BioRevolution ETF
SYNB

Delisted

SYNB was delisted on the 13th of November, 2025.

Back to rankings

1 hedge funds and large institutions have $3.1M invested in Putnam BioRevolution ETF in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
+$3.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
1
Putnam Investments
Massachusetts
$3.1M +$3.1M +125,000 New

SYNB Hedge Fund Activity: Q3 2022 in Review

1 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q3 2022, worth a combined $3.1M.

Buyers outnumbered sellers: 1 fund opened new SYNB positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Putnam Investments, opening a new position worth an estimated $3.1M.

  • 1 institutional investor held Putnam BioRevolution ETF (SYNB) as of Q3 2022, up from 0 in Q2 2022.
  • Funds reported $3.1M of Putnam BioRevolution ETF stock for Q3 2022.
  • 1 fund opened new Putnam BioRevolution ETF positions in Q3 2022 and 0 closed out, a net change of +1 holder.
  • The largest Putnam BioRevolution ETF buyer in Q3 2022 was Putnam Investments, an estimated $3.1M added.

Based on aggregated 13F filings for Q3 2022.